• 1
    Whyte MP (2001) Hypophosphatasia. In The Metabolic and Molecular Bases of Inherited Diseases, Vol. 4, 8th edn (Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler KW & Vogelstein B, eds), pp. 53195329. McGraw-Hill, New York.
  • 2
    Whyte MP (2010) Physiological role of alkaline phosphatase explored in hypophosphatasia. Ann NY Acad Sci 1192, 190200.
  • 3
    Millán JL (2006) Mammalian Alkaline Phosphatases: From Biology to Applications in Medicine and Biotechnology. Wiley-VCH, Weinheim.
  • 4
    Mornet E (2007) Hypophosphatasia. Orphanet J Rare Dis 2, 40.
  • 5
    Waymire KG, Mahuren JD, Jaje JM, Guilarte TR, Coburn SP & MacGregor GR (1995) Mice lacking tissue non-specific alkaline phosphatase die from seizures due to defective metabolism of vitamin B-6. Nat Genet 11, 4551.
  • 6
    Narisawa S, Fröhlander N & Millán JL (1997) Inactivation of two mouse alkaline phosphatase genes and establishment of a model of infantile hypophosphatasia. Dev Dyn 208, 432446.
  • 7
    Fedde KN, Blair L, Silverstein J, Coburn SP, Ryan LM, Weinstein RS, Waymire K, Narisawa S, Millán JL, MacGregor GR et al. (1999) Alkaline phosphatase knock-out mice recapitulate the metabolic and skeletal defects of infantile hypophosphatasia. J Bone Miner Res 14, 20152026.
  • 8
    Russell RG, Bisaz S, Donath A, Morgan DB & Fleisch H (1971) Inorganic pyrophosphate in plasma in normal persons and in patients with hypophosphatasia, osteogenesis imperfect, and other disorders of bone. J Clin Invest 50, 961969.
  • 9
    Nasu M, Ito M, Ishida Y, Numa N, Komaru K, Nomura S & Oda K (2006) Aberrant interchain disulfide bridge of tissue-nonspecific alkaline phosphatase with an Arg433-Cys substitution. FEBS J 273, 56125624.
  • 10
    Numa N, Ishida Y, Nasu M, Sohda M, Misumi Y, Noda T & Oda K (2008) Molecular basis of perinatal hypophosphatasia with tissue-nonspecific alkaline phosphatase bearing a conservative replacement of valine by alanine at position 406. Structural importance of the crown domain. FEBS J 275, 27272737.
  • 11
    Komaru K, Ishida Y, Amaya Y, Goseki-Sone M, Orimo H & Oda K (2005) Novel aggregate formation of a frame-shift mutant protein of tissue-nonspecific alkaline phosphatase is ascribed to three cysteine residues in the C-terminal extension, Retarded secretion and proteasomal degradation. FEBS J 272, 17041717.
  • 12
    Shibata H, Fukushi M, Igarashi A, Misumi Y, Ikehara Y, Ohashi Y & Oda K (1998) Defective intracellular transport of tissue-nonspecific alkaline phosphatase with an Ala162-Thr mutation associated with lethal hypophosphatasia. J Biochem (Tokyo) 123, 968977.
  • 13
    Fukushi-Irie M, Ito M, Amaya Y, Amizuka N, Ozawa H, Omura S, Ikehara Y & Oda K (2000) Possible interference between tissue-non-specific alkaline phosphatase with an Arg54-Cys substitution and a counterpart with an Asp277-Ala substitution found in a compound heterozygote associated with severe hypophosphatasia. Biochem J 348, 633642.
  • 14
    Ishida Y, Komaru K, Ito M, Amaya Y, Kohno S & Oda K (2003) Tissue-nonspecific alkaline phosphatase with an Asp289-Val mutation fails to reach the cell surface and undergoes proteasome-mediated degradation. J Biochem (Tokyo) 134, 6370.
  • 15
    Ito M, Amizuka N, Ozawa H & Oda K (2002) Retention at the cis-Golgi and delayed degradation of tissue-non-specific alkaline phosphatase with an Asn153 to Asp substitution, a cause of perinatal hypophosphatasia. Biochem J 361, 473480.
  • 16
    Brun-Heath I, Lia-Baldini A-S, Maillard S, Taillandier A, Utsch B, Nunes ME, Serre J-L & Mornet E (2007) Delayed transport of tissue-nonspecific alkaline phosphatase with missense mutations causing hypophosphatasia. Eur J Med Genet 50, 367378.
  • 17
    Cai G, Michigami T, Yamamoto T, Yasui N, Satomura K, Yamagata M, Shima M, Nakajima S, Mushiake S, Okada S et al. (1998) Analysis of localization of mutated tissue-nonspecific alkaline phosphatase proteins associated with neonatal hypophosphatasia using green fluorescent protein chimeras. J Clin Endocrinol Metab 83, 39363942.
  • 18
    Lia-Baldini AS, Brun-Heath I, Carrion C, Simon-Bouy B, Serre JL, Numes ME & Mornet E (2008) A new mechanism of dominance in hypophosphatasia: the mutated protein can disturb the cell localization of the wild-type protein. Hum Genet 123, 429432.
  • 19
    Ishida Y, Komaru K & Oda K (2011) Molecular characterization of tissue-nonspecific alkaline phosphatase with an Ala to Thr substitution at position 116 associated with dominantly inherited hypophosphatasia. Biochim Biophys Acta 1812, 326332.
  • 20
    Mornet E, Stura E, Lia-Baldini AS, Stigbrand T, Ménez A & Le Du MH (2001) Structural evidence for a functional role of human tissue nonspecific alkaline phosphatase in bone mineralization. J Biol Chem 276, 3117131178.
  • 21
    Le Du MH, Stigbrand T, Taussig MJ, Menez A & Stura EA (2001) Crystal structure of alkaline phosphatase from human placenta at 1.8 A resolution. Implication for substrate specificity. J Biol Chem 276, 91589165.
  • 22
    Fauvert D, Brun-Heath I, Lia-Baldini AS, Bellazi L, Taillandier A, Serre JL, de Mazancourt P & Mornet E (2009) Mildform forms of hypophosphatasia most result from dominant negative effect of severe alleles or from compound heterozygosity for severe and moderate alleles. BMC Med Genet 10, 51.
  • 23
    Satou Y, Al-Shawafi HA, Sultana S, Makita S, Sohda M & Oda K (2012) Disulfide bonds are critical for tissue-nonspecific alkaline phosphatase function revealed by analysis of mutant proteins bearing a C201-Y or C489-S substitution associated with severe hypophosphatasia. Biochim Biophys Acta 1822, 581588.
  • 24
    Le Du MH & Millán JL (2002) Structural evidence of functional divergence in human alkaline phosphatases. J Biol Chem 277, 4980849814.
  • 25
    Bossi M, Hoylaerts MF & Millán JL (1993) Modifications in a flexible surface loop modulate the isozyme-specific properties of mammalian alkaline phosphatases. J Biol Chem 268, 2540925416.
  • 26
    Di Mauro S, Manes T, Hessle L, Kozlenkov A, Pzauro JM, Hoylarts MF & Millán JL (2002) Kinetic characterization of hypophosphatasia mutations with physiological substrates. J Bone Miner Res 17, 13831391.
  • 27
    Whyte MP, Kurtzberg J, McAlister WH, Mumm S, Podgornik MN, Coburn SP, Ryan LM, Miller CR, Gottesman GS, Smith AK et al. (2003) Marrow cell transplantation for infantile hypophosphatasia. J Bone Miner Res 18, 624636.
  • 28
    Cahill RA, Wenkert D, Perlman SA, Steele A, Coburn SP, McAlister WH, Mumm S & Whyte MP (2007) Infantile hypophosphatasia: transplantation therapy trial using bone fragments and cultured osteoblasts. J Clin Endocrinol Metab 92, 29232930.
  • 29
    Whyte MP, Mumm S & Deal C (2007) Adult hypophosphatasia treated with teriparatide. J Clin Endocrinol Metab 92, 12031208.
  • 30
    Katsube Y, Kotobuki N, Tadokoro M, Kanai R, Taketani T, Yamaguchi S & Ohgushi H (2010) Restoration of cellular function of mesenchymal stem cells from a hypophosphatasia patient. Gene Ther 17, 494502.
  • 31
    Yamamoto S, Orimo H, Matsumoto T, Iijima O, Narisawa S, Maeda T, Millán JL & Shimada T (2011) Prolonged survival and phenotypic correction of Akp2(–/–) hypophosphatasia mice by lentiviral gene therapy. J Bone Miner Res 26, 135142.
  • 32
    Sugano H, Matsumoto T, Miyake K, Watanabe A, Iijima O, Migita M, Narisawa S, Millán JL, Fukunaga Y & Shimada T (2012) Successful gene therapy in utero for lethal murine hypophosphatasia. Hum Gene Ther 23, 399406.
  • 33
    Millán JL, Narisawa S, Lemire I, Loisel TP, Boileau G, Leonard P, Gramatikova S, Terkeltaub R, Camacho NP, McKee MD et al. (2008) Enzyme replacement therapy for murine hypophosphatasia. J Bone Miner Res 23, 777787.
  • 34
    McKee MD, Nakano Y, Masica DL, Gray JJ, Lemire I, Heft R, Whyte MP, Crine P & Millán JL (2011) Enzyme replacement therapy prevents dental defects in a model of hypophosphatasia. J Dent Res 90, 470476.
  • 35
    Yadav MC, Lemire I, Leonard P, Boileau G, Blond L, Beliveau M, Cory E, Sah RL, Whyte MP, Crine P et al. (2011) Dose response of bone-targeted enzyme replacement for murine hypophosphatasia. Bone 9, 250256.
  • 36
    Yadav MC, de Oliveira RC, Foster BL, Fong H, Cory E, Narisawa S, Sah RL, Somerman M, Whyte MP & Millán JL (2012) Enzyme replacement prevents enamel defects in hypophosphatasia mice. J Bone Miner Res 27, 17221734.
  • 37
    Whyte MP, Greenberg CR, Salman NJ, Bober MB, McAlister WH, Wenkert D, Van Sickle BJ, Simmons JH, Edgar TS, Bauer ML et al. (2012) Enzyme-replacement therapy in life-threatening hypophosphatasia. N Engl J Med 366, 904913.
  • 38
    Rodriguez E, Bober MB, Davey L, Zamora A, Li Puma AB, Chidekel A & Shaffer TH (2012) Respiratory mechanics in an infant with perinatal lethal hypophosphatasia treated with human recombinant enzyme replacement therapy. Pediatr Pulmonol 47, 917922.
  • 39
    Oda K, Amaya Y, Fukushi-Irie M, Kinameri Y, Ohsuye K, Kubota I, Fujimura S & Kobayashi J (1999) A general method for rapid purification of soluble versions of glycosylphosphatidylinositol-anchored proteins expressed in insect cells: an application for human tissue-nonspecific alkaline phosphatase. J Biochem (Tokyo) 126, 694699.
  • 40
    Akiyama Y & Ito K (1989) Export of Escherichia coli alkaline phosphatase attached to an integral membrane protein, Sec Y. J Biol Chem 246, 437442.